Lambertini M

Publishing 2017

Is this you? Claim this profile
1
Article
273
Reads on Journament
4
Co-authors
1
Journal

This page collects the articles indexed under the name Lambertini M. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. emerging treatments for her2-positive early-stage breast cancer: focus on neratinib
    jurnal tam 2017 273 reads

Possible papers by Lambertini M 5

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Response to Ergun and to Zhu and Liu
    as Matteo Lambertini JNCI Journal of the National Cancer Institute 2026
    Same name only
  2. Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis
    as Matteo Lambertini JNCI Journal of the National Cancer Institute 2026
    Same name only
  3. Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib
    as Matteo Lambertini JNCI Journal of the National Cancer Institute 2026
    Same name only
  4. Prognostic impact of PTEN status in recurrent IDH-wildtype glioblastoma receiving second-line therapy
    as Matteo Lambertini Neuro-Oncology Advances 2026
    Same name only
  5. Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort
    as Matteo Lambertini jnci cancer spectrum 2026
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in